Complement is Activated by Coagulation and not by Chitosan in Human Whole Blood and Plasma

Authors

  • Edward Baraghis Department of Chemical Engineering
  • Catherine Marchand Institute for Biomedical Engineering, École Polytechnique
  • Georges-Etienne Rivard Division of Hematology-Oncology, Hôpital Sainte-Justine
  • Caroline D. Hoemann Department of Chemical Engineering, Institute for Biomedical Engineering, École Polytechnique

Abstract

Chitosan is a biocompatible and adhesive polysaccharide scaffold composed of glucosamine and N-acetyl glucosamine. We previously showed that liquid chitosan buffered with glycerol phosphate (chitosan-GP) can be homogenously mixed into whole blood to form an in situ-solidifying clot implant that stimulates transient neutrophil chemotaxis during marrow-based regeneration of articular cartilage. Thrombin was recently shown to activate complement, a family of plasma proteases whose activation culminates in the cleavage of a C5 precursor to produce a potent neutrophil chemotactic factor, C5a.

Solid chitosan particles were previously reported to activate complement in serum and plasma through the alternative pathway. We therefore tested the hypothesis that liquid chitosan-GP activates complement in human whole blood, plasma, and serum. 

Downloads

Published

2008-06-11

How to Cite

[1]
E. Baraghis, C. Marchand, G.-E. Rivard, and C. D. Hoemann, “Complement is Activated by Coagulation and not by Chitosan in Human Whole Blood and Plasma”, CMBES Proc., vol. 31, no. 1, Jun. 2008.

Issue

Section

Academic